We have demonstrated that NR5A1 overexpression in ACC cells regulates the expression of both positive and negative dosage-dependent target genes which are directly implicated in shaping the malignant tumour phenotype (3–8). The gene discussed is NR5A1; the disease is adrenal cortex carcinoma.